Upregulated TRIM32 correlates with enhanced cell proliferation and poor prognosis in hepatocellular carcinoma.
Cui X, Lin Z, Chen Y, Mao X, Ni W, Liu J, Zhou H, Shan X, Chen L, Lv J, Shen Z, Duan C, Hu B, Ni R.
Cui X, et al. Among authors: hu b.
Mol Cell Biochem. 2016 Oct;421(1-2):127-37. doi: 10.1007/s11010-016-2793-z. Epub 2016 Aug 30.
Mol Cell Biochem. 2016.
PMID: 27573002
Clinical Trial.